WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
Air quality improved, not everywhere below limit values In recent years there has been a decline in the average concentrations of fine particulates and nitrogen dioxide.
Measures EU cities against effects of climate change Some European cities have developed effective policies to adapt to more frequent wet and dry periods forecast for the years ahead, as a result of climate change.
Further research into hazards posed by e-cigarettes Safety of nicotine-containing electronic cigarettes (e-cigarettes) cannot be confirmed because of the limited amount of published research in this area.
Jaap van Dissel appointed as Director of the RIVM Centre for Infectious Disease Control Prof Jaap van Dissel is appointed as Director of the RIVM Centre for Infectious Disease Control. He takes up the post on 15 August and succeeds Prof.
Extra measles vaccinations for risk groups Some areas of the Netherlands where families for religious reasons chose not to get their babies vaccinated are now reporting cases of measles, and it is expected that the number of cases will incr
Fewer municipalities with low vaccination coverage In the Netherlands, there are 80 municipalities with a low vaccination coverage for one or more vaccinations. This is a decrease compared to last year when there were still 90 municipalities.
More people visiting STI clinics in 2012 with chlamydia and gonorrhea infections In 2012, the number of new consultations at Sexually Transmitted Infections (STI) clinics in the Netherlands increased by 7% over the previous year.